Evaluation of allele frequencies in the PADI4 gene and anti-cyclic citrullinated peptide antibodies of patients with rheumatoid arthritis in a Japanese population

被引：4
|
作者：
Suzuki, M.
Miyagi, J.
Kuribayashi, M.
Negishi, E.
Ueno, K.
Moriya, H.
机构：
[1] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Geriatr Pharmacol, Chuo Ku, Chiba 2608670, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 10期
关键词：
D O I：
10.1136/ard.2006.052431
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1399 / 1400
页数：2
相关论文
共 50 条
  • [1] Polymorphisms and functional haplotype in PADI4: Further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population
    Paola Guzman-Guzman, Iris
    Reyes-Castillo, Zyanya
    Munoz-Barrios, Salvador
    Ruiz-Noa, Yeniley
    Esther Martinez-Bonilla, Gloria
    Parra-Rojas, Isela
    Azucena Palafox-Sanchez, Claudia
    Francisco Munoz-Valle, Jose
    IMMUNOLOGY LETTERS, 2015, 163 (02) : 214 - 220
  • [2] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [3] Evaluation of a functional haplotype of the PADI4 gene and anti CCP antibodies of rheumatoid arthritis in the Japanese population.
    Suzuki, M
    Miyagi, J
    Tahara, M
    Kamoda, H
    Kuribayasi, M
    Negishi, E
    Sasho, T
    Haneda, A
    Ueno, K
    Moriya, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S150 - S150
  • [4] Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort
    Du, Y.
    Liu, X.
    Guo, J. P.
    Liu, X.
    Li, R.
    Zhao, Y.
    Liu, X.
    Li, M. H.
    Li, Z. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (03) : 377 - 382
  • [5] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [6] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
  • [7] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    V Michael Holers
    Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
  • [8] Anti-cyclic citrullinated peptide antibodies in juvenile rheumatoid arthritis patients.
    Moore, TL
    Chung, AK
    Kietz, DA
    Pepmueller, PH
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S338 - S338
  • [9] Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
    Al-Shukaili, Ahmed
    Al-Ghafri, Saif
    Al-Marhoobi, Safia
    Alkaabi, Juma
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [10] Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis
    Cha, Seongwon
    Choi, Chan-Bum
    Han, Tae-Un
    Kang, Changsoo Paul
    Kang, Changwon
    Bae, Sang-Cheol
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1454 - +
12345